December 2021 OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet Benjamin Franklin Medal in Chemistry from The Franklin Institute "Huge congratulations to our founder, Carol

pharmacology' Yao Lu and colleagues work on 'Molecular insights into orphan GPCRs relevant to schizophrenia' Carole Daly and their team research on 'β-arrestin-dependent and -independent endosomal GPCR activation by

February 2022 "Switzerland Today, InterAx Biotech is pleased to announce that Carola Weiss has joined Carola Weiss is a Senior Executive with more than 20 years of international experience in the biopharmaceutical Carola Weiss’ professional career brings deep expertise in business development, marketing & sales, licensing

December 2021 "Dame Carol Robinson DBE, FRS, FRSC, FMedSci, Oxford University’s first female Professor

Industry News Professor Dame Carol Robinson Received 2023 ASMS John.B.Fenn Award Exscientia Announces

Good day, GPCR folks! Take advantage of our GPCR highlights of the week. Dr. Kathleen Caron. Check out the weekly Classified GPCR News from October 30 to November 4, 2023. Receives R&D Achievement of the Year Award for GPCR Research Bryan Roth, Natural Products, and the John Daly

August 2022 "THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 /PRNewswire/ -- Amgen (NASDAQ

ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis "SAN CARLOS

research Trinh Trung Duong Nguyen ,  Ziaurrehman Tanoli ,  Saad Hassan , Umut Onur Özcan ,   Jimmy Caroli and models of physiological ligand complexes Luis P Taracena Herrera , Søren N Andreassen ,   Jimmy Caroli Get your 5-day free trial TODAY!

Adopted by European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) "SAN CARLOS

This year's symposium will feature a trainee day with a career panel. GPCRs, Ion Channels, and Transport Proteins (March 24 - 29, 2024) GPCR Jobs NEW Postdoctoral Fellow, Caron

The symposium will feature a trainee day with a career panel. Remember to subscribe to Dr. Senior Scientist- Membrane Technologies NEW Computational Protein Design (GPCR) Postdoctoral Fellow, Caron

Kathleen Caron. Check out the weekly Classified GPCR News from October 23rd to 29th, 2023. Improving Hematopoietic Stem Cell Mobilization Using Propranolol with GPC-100 Sosei Heptares to Host R&D Day

Surgery Senior Scientist- Membrane Technologies Computational Protein Design (GPCR) Postdoctoral Fellow, Caron

Kathleen Caron, as our video guest, subscribe now!

April is the month of DNA Day, a special day commemorating the discovery of the DNA double helix structure In the United States, DNA Day was officially celebrated on April 25th, 2003. What does DNA Day have to do with GPCRs? As we celebrate Happy DNA Day, it's a testament to how genomics has revolutionized our understanding S., Caron, M. G., Lefkowitz, R. J., & Strader, C. D. (1986).

Kathleen M Caron and her team studied the GPER/GPR30 complex with β1-adrenergic receptor and AKAP5 in

Slosky LM, Caron MG, Barak LS. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery. Carroll S. Why even physicists still don't understand quantum theory 100 years on.

valbenazine, a selective vesicular monoamine transporter 2 (VMAT2) inhibitor being investigated as a once-daily

This proprietary nature limits direct access to the model and imposes a cap on daily predictions.

HTL0027477, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease Crinetics’ Once-Daily

Good day readers! Welcome to our latest GPCR updates. This week's highlights: Dr. the 5-HT2C receptor as a therapeutic target for substance use disorders Industry News Crinetics’ Once-Daily

The daily failures and rejections of research require an intrinsic motivation that goes beyond job titles

That decline may not disrupt daily operations, but it quietly weakens positioning long before biotech

Teams need to know how priorities show up in daily work, milestones, and resource allocation.

This leads to strikingly long in vitro receptor occupancy durations (at least seven days), meaning that Twice-daily treatment with mOB-004 dose-dependently suppressed monocyte infiltration into the peritoneum

work related to GPCR-mediated signaling was the 1947 Nobel Prize in Physiology or Medicine, awarded to Carl including glycogenolysis.[33–39] In their work, the duo further investigated the work of Gerty Cori and Carl Carl Cori – Facts - NobelPrize.org. https://www.nobelprize.org/prizes/medicine/1947/cori-cf/facts/. 4 Carl F. Cori and Mrs. Cori. Histamine pharmacology: from Sir Henry Dale to the 21st century.